AusPAR Attachment 2: Extract from the Clinical Evaluation ...

analysed ECG effects at baseline, Day 6 and Day 10 from 160 participants in 4 groups; pirfenidone 2,403 mg/day, pirfenidone 4,005 mg/day, placebo and moxifloxacin Day 10, and placebo only. Upper bound of the 95% confidence interval was < 10 ms for the therapeutic (Group I) and supra therapeutic (Group II) treatment groups at all the time points. ................
................